Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study

E Focà; GIOVANNI CAVAGLIA'; S Rusconi; A Cascavilla; G Cenderello; A Re; S Casari; L van den Bogaart; Zinzani PL; D Caracciolo; Perri G Di; A Bonito; A Lucchini; G Cassola; P Viale; Andrea CALCAGNO

doi:10.1111/hiv.12624

Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study

E Focà
, GIOVANNI CAVAGLIA'
, S Rusconi
, A Cascavilla
, G Cenderello
, A Re
, S Casari
, L van den Bogaart
, Zinzani PL
, D Caracciolo
, Perri G Di
, A Bonito
, A Lucchini
, G Cassola
, P Viale
, Andrea CALCAGNO

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Lingua originale	Inglese
pagine (da-a)	523-531
Numero di pagine	9
Rivista	HIV Medicine
Volume	19
Numero di pubblicazione	8
DOI	https://doi.org/10.1111/hiv.12624
Stato di pubblicazione	Pubblicato - 2018

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

drug-to-drug interactions
HIV
lymphoma
protease inhibitors
toxicity
Health Policy
Infectious Diseases
Pharmacology (medical)

Accesso al documento

10.1111/hiv.12624

https://hdl.handle.net/11579/216900

Altri file e collegamenti

handle

Cita questo

Focà, E., CAVAGLIA', GIOVANNI., Rusconi, S., Cascavilla, A., Cenderello, G., Re, A., Casari, S., van den Bogaart, L., PL, Z., Caracciolo, D., Di, P. G., Bonito, A., Lucchini, A., Cassola, G., Viale, P., & CALCAGNO, A. (2018). Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study. HIV Medicine, 19(8), 523-531. https://doi.org/10.1111/hiv.12624

@article{b33b43acdf764d6a99bae257bd341da1,

title = "Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study",

keywords = "drug-to-drug interactions, HIV, lymphoma, protease inhibitors, toxicity, Health Policy, Infectious Diseases, Pharmacology (medical), drug-to-drug interactions, HIV, lymphoma, protease inhibitors, toxicity, Health Policy, Infectious Diseases, Pharmacology (medical)",

author = "E Foc{\`a} and GIOVANNI CAVAGLIA' and S Rusconi and A Cascavilla and G Cenderello and A Re and S Casari and \{van den Bogaart\}, L and Zinzani PL and D Caracciolo and Di, \{Perri G\} and A Bonito and A Lucchini and G Cassola and P Viale and Andrea CALCAGNO",

year = "2018",

doi = "10.1111/hiv.12624",

language = "English",

volume = "19",

pages = "523--531",

journal = "HIV Medicine",

issn = "1464-2662",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "8",

}

Focà, E, CAVAGLIA', GIOVANNI, Rusconi, S, Cascavilla, A, Cenderello, G, Re, A, Casari, S, van den Bogaart, L, PL, Z, Caracciolo, D, Di, PG, Bonito, A, Lucchini, A, Cassola, G, Viale, P & CALCAGNO, A 2018, 'Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study', HIV Medicine, vol. 19, n. 8, pagg. 523-531. https://doi.org/10.1111/hiv.12624

TY - JOUR

T1 - Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study

AU - Focà, E

AU - CAVAGLIA', GIOVANNI

AU - Rusconi, S

AU - Cascavilla, A

AU - Cenderello, G

AU - Re, A

AU - Casari, S

AU - van den Bogaart, L

AU - PL, Zinzani

AU - Caracciolo, D

AU - Di, Perri G

AU - Bonito, A

AU - Lucchini, A

AU - Cassola, G

AU - Viale, P

AU - CALCAGNO, Andrea

PY - 2018

Y1 - 2018

KW - drug-to-drug interactions

KW - HIV

KW - lymphoma

KW - protease inhibitors

KW - toxicity

KW - Health Policy

KW - Infectious Diseases

KW - Pharmacology (medical)

KW - drug-to-drug interactions

KW - HIV

KW - lymphoma

KW - protease inhibitors

KW - toxicity

KW - Health Policy

KW - Infectious Diseases

KW - Pharmacology (medical)

UR - https://iris.uniupo.it/handle/11579/216900

U2 - 10.1111/hiv.12624

DO - 10.1111/hiv.12624

M3 - Article

SN - 1464-2662

VL - 19

SP - 523

EP - 531

JO - HIV Medicine

JF - HIV Medicine

IS - 8

ER -